Filing Flows › Bodhi Tree Biotechnology (BDTB) › Q4 FY25
Bodhi Tree Biotechnology (BDTB) Q4 FY25 earnings results (fourth quarter fiscal 2025)
10-K filed Dec 29, 2025
Bodhi Tree Biotechnology (BDTB) reported revenue of $12K for the fourth quarter fiscal 2025 (Q4 FY25), -40% from a year earlier. Operating margin was -89.1%, net loss $11K (89.1% of revenue).
Bodhi Tree Biotechnology, Q4 FY25: revenue $12K (-40% year over year), operating margin -89.1%, net loss $11K, operating cash flow −$10K. The chart follows the revenue to costs, profit and cash.
| Q4 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12K | — | -40% |
| Operating profit | −$11K | — | — |
| Net earnings | −$11K | — | — |
| Operating cash flow | −$10K | — | — |
What changed
Revenue was $12K in Q4 FY25, down 40% year over year.
Operating costs exceeded revenue by $11K, an operating margin of -89.1%. Total costs fell 75% while revenue fell 40%. The quarter ended with a net loss of $11K.
Operating cash flow was −$10K. Working capital and other items added $1K.
Questions
What was Bodhi Tree Biotechnology's revenue in the fourth quarter fiscal 2025?
Bodhi Tree Biotechnology (BDTB) reported revenue of $12K for the fourth quarter fiscal 2025 (Q4 FY25), -40% from a year earlier.
Was Bodhi Tree Biotechnology profitable in the fourth quarter fiscal 2025?
Operating loss was $11K (-89.1% of revenue) and net loss $11K.